Ezetimibe for Patients With Chronic Hepatitis D

Exclusion Criteria

• •Decompensated liver disease
• •Patients with ALT levels greater than 10 times ULN (400 U/L)
• •Pregnancy or inability to practice adequate contraception.
• •Significant systemic or major illnesses other than liver disease, including, but not limited to, congestive heart failure, renal failure (eGFR\<50 ml/min), organ transplantation, serious psychiatric disease or depression and active coronary artery disease.
• •Systemic immunosuppressive therapy
• •Evidence of another form of liver disease in addition to viral hepatitis
• •Active substance abuse, such as alcohol or injection drugs
• •Hepatocellular carcinoma
• •Concurrent hepatitis C infection or HIV coinfection
• •Diagnosis of malignancy in the five years
• •Concurrent usage of statins
• •Concurrent use of any other drug known to inhibit NTCP
• •Inability to understand or sign informed consent
• •Any other condition, which in the opinion of the investigators would impede the patient's participation or compliance in the study